| RS5964007 |
CASK
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, CASK-related |
| RS59662841 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephalic osteodysplastic primordial dwarfism type II, PCNT-related disorder |
| RS59684335 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Dilated cardiomyopathy 1S |
| RS59685571 |
KRT6A
|
Health Risk |
Pathogenic |
Pachyonychia congenita 3, Pachyonychia congenita 3 |
| RS5969 |
F11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary factor XI deficiency disease, Plasma factor XI deficiency |
| RS59690629 |
DNAH17
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, DNAH17-related disorder |
| RS59691602 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Pigmented paravenous retinochoroidal atrophy |
| RS59709076 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS59730172 |
KRT5
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 2C, localized |
| RS59759676 |
CEP135
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS59793293 |
GFAP
|
Health Risk |
Pathogenic |
Alexander disease, Alexander disease |
| RS5982 |
F13A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor XIII, A subunit |
| RS5983 |
F13A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor XIII, A subunit |
| RS59840738 |
KRT5
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex, Epidermolysis bullosa simplex 2B |
| RS59844753 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS5985 |
F13A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Myocardial infarction, protection against |
| RS59852838 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic diabetes, Permanent neonatal diabetes mellitus |
| RS59856285 |
KRT16
|
Health Risk |
Pathogenic |
Palmoplantar keratoderma, nonepidermolytic |
| RS59878153 |
KRT9
|
Health Risk |
Pathogenic |
Epidermolytic palmoplantar keratoderma, 1 |
| RS59885338 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2B1, Charcot-Marie-Tooth disease type 2 |
| RS59886214 |
LMNA
|
Health Risk |
Pathogenic |
Hutchinson-Gilford syndrome, Hutchinson-Gilford syndrome |
| RS5989 |
F13A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor XIII, A subunit |
| RS59897026 |
KRT13
|
Health Risk |
Pathogenic |
White sponge nevus 2, White sponge nevus 2 |
| RS5991 |
F13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor XIII, b subunit |
| RS59912693 |
IFT122
|
Health Risk |
Conflicting classifications of pathogenicity |
Cranioectodermal dysplasia 1, Inborn genetic diseases |
| RS59914820 |
LMNA
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS59915619 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS59931416 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular dystrophy due to LMNA mutation, Charcot-Marie-Tooth disease type 2 |
| RS59933498 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS5994 |
F13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor XIII, b subunit |
| RS59950911 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS59952053 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, childhood absence |
| RS59956343 |
ENPP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Arterial calcification, generalized |
| RS59962885 |
DES
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1I, Desmin-related myofibrillar myopathy |
| RS59966597 |
KRT14
|
Health Risk |
Pathogenic |
Palmoplantar blistering, Skin fragility with non-scarring blistering |
| RS59977263 |
KRT17
|
Health Risk |
Pathogenic |
Pachyonychia congenita 2, Pachyonychia congenita 2 |
| RS59978698 |
CCDC40
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS59981161 |
LMNA
|
Health Risk |
Pathogenic |
Familial partial lipodystrophy, Dunnigan type |
| RS5999 |
F13B
|
Health Risk |
Conflicting classifications of pathogenicity |
F13B-related disorder, Factor XIII |
| RS60035576 |
KRT10
|
Health Risk |
Pathogenic |
Epidermolytic hyperkeratosis 2B, autosomal recessive |
| RS60040113 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperaldosteronism, familial |
| RS6006 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Budd-Chiari syndrome, Factor V deficiency |
| RS6007 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor V deficiency, Thrombophilia due to activated protein C resistance |
| RS6008 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor V deficiency, Budd-Chiari syndrome |
| RS60090257 |
KRT14
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 1A, generalized severe |
| RS6010209 |
TUBGCP6
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly and chorioretinopathy 1, Inborn genetic diseases |
| RS60103800 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 2, Usher syndrome type 1 |
| RS6011 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor V deficiency, Thrombocytopenia |
| RS6011230 |
DNAJC5
|
Health Risk |
Conflicting classifications of pathogenicity |
Ceroid lipofuscinosis, neuronal |
| RS60118264 |
KRT10
|
Health Risk |
Pathogenic |
Epidermolytic hyperkeratosis 2A, autosomal dominant |
| RS60171927 |
KRT14
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 1A, generalized severe |
| RS60184489 |
ZFYVE26
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 15, Spastic paraplegia |
| RS60185966 |
LRRK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Parkinson disease 8, Autosomal dominant Parkinson disease 8 |
| RS60203778 |
PEX13
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 11A (Zellweger), PEX13-related disorder |
| RS60216939 |
ATN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dentatorubral-pallidoluysian atrophy, Dentatorubral-pallidoluysian atrophy |
| RS60231560 |
KRT14
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 1D, generalized |
| RS6025 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Budd-Chiari syndrome, susceptibility to |
| RS60261494 |
NEFL
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 1F, Charcot-Marie-Tooth disease type 2E |
| RS6026588 |
GNAS
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS60269890 |
GFAP
|
Health Risk |
Pathogenic |
Alexander disease, Alexander disease |
| RS60271599 |
KRT5
|
Health Risk |
Pathogenic |
— |
| RS60279874 |
PNKP
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly, seizures |
| RS60284677 |
AP5Z1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 48, Hereditary spastic paraplegia |
| RS60290646 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS60297570 |
KRT1
|
Health Risk |
Likely pathogenic |
— |
| RS6030 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombophilia due to activated protein C resistance, Congenital factor V deficiency |
| RS60310264 |
LMNA
|
Health Risk |
Pathogenic |
Hutchinson-Gilford progeria syndrome, atypical |
| RS60338701 |
KRT14
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex, Epidermolysis bullosa simplex |
| RS6034 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombophilia due to activated protein C resistance, Factor V deficiency |
| RS60343255 |
GFAP
|
Health Risk |
Pathogenic |
Alexander disease, Alexander disease |
| RS60352920 |
KRT14
|
Health Risk |
Pathogenic |
— |
| RS60373464 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral arteriopathy, autosomal dominant |
| RS60376624 |
SLC22A5
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS60399023 |
KRT14
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 1A, generalized severe |
| RS60407644 |
SGCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy |
| RS60410063 |
KRT3
|
Health Risk |
Pathogenic |
Corneal dystrophy, Meesmann |
| RS604131 |
HBA1
|
Health Risk |
Likely pathogenic |
alpha Thalassemia, alpha Thalassemia |
| RS60431989 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
Wilson disease, Inborn genetic diseases |
| RS60440396 |
KRT13
|
Health Risk |
Pathogenic |
White sponge nevus 2, White sponge nevus 2 |
| RS60445853 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS60446065 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS60447237 |
KRT1
|
Health Risk |
Pathogenic |
Diffuse nonepidermolytic palmoplantar keratoderma, Diffuse nonepidermolytic palmoplantar keratoderma |
| RS60451214 |
CNTNAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS6045440 |
SEC23B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital dyserythropoietic anemia, type II |
| RS60458016 |
LMNA
|
Health Risk |
Pathogenic |
Emery-Dreifuss muscular dystrophy 2, autosomal dominant |
| RS6046 |
F7
|
Health Risk |
Conflicting classifications of pathogenicity |
Myocardial infarction, decreased susceptibility to |
| RS60466225 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS60470268 |
KRT14
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex, Epidermolysis bullosa simplex |
| RS60484572 |
DHFR;MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Endometrial carcinoma |
| RS60504011 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS60538473 |
DES
|
Health Risk |
Pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS6053893 |
FERMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kindler syndrome, FERMT1-related disorder |
| RS6054 |
FGB
|
Health Risk |
Conflicting classifications of pathogenicity |
Abnormal bleeding, Congenital afibrinogenemia |
| RS6055363 |
HAO1
|
Health Risk |
association |
Nephrolithiasis, calcium oxalate |
| RS60554162 |
KRT6A
|
Health Risk |
Pathogenic/Likely pathogenic |
Pachyonychia congenita 3, Pachyonychia congenita 3 |
| RS60578328 |
LMNA
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1A, Dilated cardiomyopathy 1A |
| RS6058017 |
ASIP
|
Health Risk |
association |
SKIN/HAIR/EYE PIGMENTATION 9, DARK/LIGHT HAIR |
| RS60586163 |
KRT5
|
Health Risk |
Pathogenic/Likely pathogenic |
Epidermolysis bullosa simplex, Epidermolysis bullosa simplex 2C |
| RS6060148 |
MYH7B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS60612575 |
KRT86
|
Health Risk |
Pathogenic |
Monilethrix, Monilethrix |